SyncThink, a Boston-based applying VR and eye-tracking to assess ability to focus as an indicator of concussion damage, has launched the next generation of its FDA-cleared EYE-SYNC platform.
The US Food and Drug Administration (FDA) has granted breakthrough designation for SyncThink's Eye-Sync technology, a virtual reality eye-tracking platform that provides objective measurements to aid ...
In a new study led by Children's Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision disorders, a common phenomenon ...
Philadelphia, July 30, 2025 – In a new study led by Children’s Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision ...
Nearly half of adolescents and young adults with lingering symptoms of concussion suffer from eye coordination disorders that cause double and blurred vision, headaches and difficulties concentrating.
Boston-based eye tracking company SyncThink has made major changes to its marketing materials since the FDA objected to its labeling in a warning letter. The letter is dated July 31st; MedCityNews ...
In a new study led by Children's Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision disorders, a common phenomenon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results